ResMed Inc. (RMD) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello and welcome to the Q4 fiscal year 2025 ResMed earnings conference call. My name is Kevin. I'll be your operator for today's call. At this time, all participants are in listen-only mode. Also, please note this conference call is being recorded. Later, we'll conduct a question and answer session. Let me hand the call over to Sally Schwartz, ResMed's Chief Investor Relations Officer. Sally, please go ahead. Thanks, Kevin. I want to welcome our listeners to ResMed's fourth quarter fiscal year 2025 earnings call. We are live webcasting this call from Sydney, and the replay will be available on the investor relations section of our corporate website later today. Our earnings press release and presentation are both available online now. During today's call, we will discuss several non-GAAP measures that we believe provide useful information for investors. This information is not intended to be considered in isolation or as a substitute for GAAP financial information. We encourage you to review the supporting schedules in today's earnings press release to reconcile these non-GAAP measures with the GAAP-reported numbers. In addition, our discussion today will include forward-looking statements, including, but not limited to, expectations about our future financial and operating performance. We make these statements based on reasonable assumptions. However, our actual results could differ. Please review our SEC filings for a complete discussion of the risk factors that could cause our actual results to differ materially from any forward-looking statements made today. I'll now turn the call over to Mick. Thank you, Sally, and good morning from a wintry, cold and rainy Sydney, Australia. Good afternoon to those in the US and good evening to those in Europe and beyond. And ...